The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex The World Health Organization (WHO) has announced that it has added Bavarian Nordic’s mpox vaccine to its list of ...

New evidence highlights AI’s potential in early lung cancer detection At the IASLC 2024 World Conference on Lung Cancer in San Diego, a new study has demonstrated that AI-powered chest X-ray ...

Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has announced that its partner, Centessa Pharmaceuticals, has reported encouraging ...

The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley as Acting President. Abberley, who is General Manager of Amgen UK and Ireland, has over 25 years of life ...

Serac Healthcare, a clinical radiopharmaceutical company, and the University of Exeter have announced the commencement of a Phase II study involving a novel molecular SPECT imaging agent, ...

Eli Lilly and Company has announced promising results from two phase 3 clinical trials, QWINT-1 and QWINT-3, evaluating the efficacy of once-weekly insulin efsitora alfa (efsitora) in adults with type ...

Speed and relevance are crucial in interactions between biopharma companies and healthcare professionals (HCPs). Data from the Digital Health Coalition reveals that only 27% of HCPs find biopharma ...

This month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our industry. Our insightful front cover article delves into the key regulatory ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Astellas Pharma’s Vyloy (zolbetuximab) as part of a first-line combination treatment for a subset of gastric cancer patients ...

200,000 people in the UK have what is considered a ‘hidden’ lung condition Bronchiectasis is the third most common lung condition in the UK but despite this, it is sometimes seen as a ‘hidden’ disease ...

The new test takes an average of 13 hours to identify the correct treatment compared to several days with current methods Press release: QuantaMatrix, a clinical microbiology diagnostics company in ...